Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Pediatrics|January 13, 2026
Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 PandemicOlla Hamdan, Justin Z Amarin, James W Antoon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2025
Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020Justin Z Amarin, Ariana P Toepfer, Andrew J Spieker, et al.
Pediatrics|April 5, 2026
Pediatric Vaccine Effectiveness Against Influenza Hospitalization And Outpatient Visits: 2021-2024Samantha M Olson, Haris M Ahmad, Kristina Wielgosz, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
Journal of the Pediatric Infectious Diseases Society|March 22, 2025
The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US ChildrenGeoffrey A Weinberg, Annabelle M de St Maurice, Yasmeen Z Qwaider, et al.
Journal of the Pediatric Infectious Diseases Society|October 10, 2024
Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective StudyHanna M Grioni, Erin Sullivan, Bonnie Strelitz, et al.
Influenza and Other Respiratory Viruses|June 11, 2025
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020Tess Stopczynski, Justin Z Amarin, James W Antoon, et al.
Pediatrics|August 5, 2025
Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative AnalysisLeah A Goldstein, Marian G Michaels, Abigail Salthouse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2024
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance StudyJames W Antoon, Justin Z Amarin, Olla Hamdan, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
Pageof 5